Cell survival signaling during apoptosis: implications in drug resistance and anti-cancer therapeutic development.

Cell survival signaling during apoptosis: implications in drug resistance and anti-cancer therapeutic development.
复制标题

DOI:
10.1007/3-7643-7414-4_6
复制
发表时间:
2005
期刊:
Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques
影响因子:
--
通讯作者:
Grace Choy;Jun-Wei Liu;D. Chandra;D. Tang
Grace Choy;Jun-Wei Liu;D. Chandra;D. Tang
中科院分区:
其他
文献类型:
--
作者:
Grace Choy;Jun-Wei Liu;D. Chandra;D. Tang

文献摘要

相似文献

DISC, death-inducing signaling complex; DED, death effector domain; DR, death receptor; DD, death domains; FADD, Fas-associated death domain; TRADD, TNF receptor 1-associated death domain; ROS, reactive oxygen species; Apaf-1, apoptotic protease-activating factor-1; IAP, inhibitor of apoptosis protein; ER, endoplasmic reticulum; PTP, permeability transition pore; MAPK, mitogen-activated protein kinase; BH3, Bcl-2 homology domain 3; c-FLIP, caspase-8-FLICE inhibitory protein; IKK, IkB kinase; RIP, receptor-interacting protein; PI3K, phosphatidylinositol 3-kinase; PK, protein kinase; PIP3, phosphatidylinositol 3-phosphate; PDK1, phosphoinositide-dependent protein kinase-1; SHIP-2, Src homology 2 domain containing inositol phosphatase; HSP, heat shock protein; FKHR1, Forkhead receptor-1; ERK, extracellular regulated kinase; Grb2, growth factor receptor-bound protein 2; SOS, son of sevenless; SODs, superoxide dismutases.